BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 28
• 29
• 30

• Drug Development

  Celator Pharmaceuticals, Inc. Presents Interim Data from Phase 2 Study of CPX-351 in Newly Diagnosed AML at American Society of Hematology Meeting

  December 7, 2009

   · 

  3 min read
• Business

  Sirona Biochem Bolsters Scientific Advisory Board With Another Top Canadian Scientist

  December 7, 2009

   · 

  4 min read
• Drug Development

  Micromet: Data from Phase 1 Study Confirm High Response Rate of Micromet’s Blinatumomab in Patients with Non-Hodgkins Lymphoma

  December 7, 2009

   · 

  3 min read
• Drug Development

  Antisoma PLC’s AS1413 Regimen Yields High Response Rate And Durable Responses In Patients With Secondary AML, A Poor-Risk Population Underserved By Current Treatment Options

  December 7, 2009

   · 

  6 min read
• BioForest

  Pyng Medical Corp. Receives First Purchase Order for CRIC(TM) Kit

  December 7, 2009

   · 

  3 min read
• Pediapharm Launches EpiCeram(R)

  December 7, 2009

   · 

  4 min read
• Drug Development

  Ambit Biosciences Announces Two Poster Presentations Characterizing The Effects of AC220 in Preclinical Models of Acute Myeloid Leukemia at American Society of Hematology Conference

  December 7, 2009

   · 

  2 min read
• Biotech Bay

  Fluidigm Corporation Releases Access Array(TM) System for 454 FLX Applicon Tagging

  December 7, 2009

   · 

  1 min read
• Deals

  Ventana Biotech Inc. Enters Final Stage of Negotiations

  December 7, 2009

   · 

  2 min read
• Novo Nordisk A/S: Transaction in Own Shares

  December 7, 2009

   · 

  2 min read